Brian Nowosielski

With the Medicare GLP-1 Bridge Program just 2 weeks old, a drug market expert shared their thoughts on what the initiative may mean for pharmacists and their patients.

Among adult patients who have reported a case of invasive pneumococcal disease, researchers address the association of risk factors and recurrent disease.

In this episode, Natalie DiPietro Mager, PharmD, PhD, talks with Mark Garofoli, PharmD, MBA, BCGP, CPE, CTTS, about how pharmacists can address cannabis use in women during adolescence, reproductive years, and older adulthood.

With GLP-1 questions creating confusion for Medicare patients, pharmacists are becoming the trusted frontline resource, and the stakes for getting it right have never been higher.

With the goal of optimizing long-term weight-loss treatment, researchers gather insights regarding the lived experiences of glucagon-like peptide-1 users.

In an assessment of pharmacy closures, researchers hypothesize underserved neighborhoods would be the most burdened locations across the country.

This episode meanders the time of the year where pharmacy professionals experience a lull in business, providing them with the perfect opportunity to invest in growth.

Jay Bregman, founder and CEO of Andel, discusses the current GLP-1 landscape and how a new Medicare initiative is designed to improve access to this increasingly popular medication class.

Researchers assess how these emerging platforms can support medication use across this patient population.

Within the arena of chronic nonmalignant pain, researchers explore barriers, facilitators, and strategies for opioid optimization services in community pharmacies.

Exploring retail pharmacy data, specifically among Walgreens locations, researchers assess the impact of closures in socially vulnerable areas.

Often operating in the shadows, LTC pharmacy is the backbone of medication management for aging and immunocompromised patients.

Among US adults with and without chronic medical conditions, researchers examine social media use for health-related information.

Prior to the study, researchers report a significant lack of exploration regarding artificial intelligence's use in antimicrobial stewardship programs conducted in pharmacy practice.

In part 2 of our interview, Esmé Grewal, JD, discusses the key opportunities LTC pharmacies possess in assisting the aging population in medication management.

Atacicept-vymj is the first medication for immunoglobulin A nephropathy that targets both B cell activating factor and a proliferation-inducing ligand inhibitors.

Through a secret shopper study, researchers assessed the process for obtaining GLP-1 therapy via the internet and the clinical engagement associated with the purchase.

Researchers assess the impact of various pneumococcal conjugate vaccines since the introduction of immunization programming.

Researchers explore how the prevalence, duration, and characteristics of post-COVID-19 symptoms varied by epidemic period.

Esmé Grewal, JD, joins to discuss the evolution of aging populations in the US and how LTC pharmacies are designed to address older adults’ outcomes.

Among patients using corticosteroids during hospital stays, researchers assess patient-reported symptoms of long COVID during follow-up.

The collaborative effort includes millions of dollars dedicated to cloud and artificial technology for a global antimicrobial resistance intelligence platform.

With the dual issue of pharmacy deserts and caregiver shortages across the US, technology is filling a much-needed gap for rural patient populations.

Episode 12 explores recent updates from the 2026 ADA Scientific Sessions, highlighting for pharmacists which technologies are making waves in the diabetes space right now.

In part 2 of our interview series with Lisa Lavin, she explored the capabilities of her company’s Home Health Hub and how it’s transforming health care access for rural populations.

In this episode, host Taylor Watterson, PharmD, PhD, welcomes Keyerrá Buckley, CPhT, ACPE administrator and technical trainer, Pharmacy Starts.

Across pharmacy type, rurality, and naloxone product type, researchers explore the changes in product availability within North Carolina from 2023 to 2025.

Researchers explore a variety of clinical services in addressing atrial fibrillation, cardiovascular risk, and social determinants of health.

Lisa Lavin, founder, chairman, and CEO of Ōmcare, discusses the Rural Health Innovation Initiative and how collaboration is bringing pharmacy care to rural Minnesota and beyond.

Machine learning can uncover immune responses to conserved pneumococcal protein antigens.